{"id":"https://openalex.org/W4415549460","doi":"https://doi.org/10.1681/asn.2025b3sepdkh","title":"Safety and Efficacy of SGLT2 Inhibitors in ANCA-Associated Vasculitis","display_name":"Safety and Efficacy of SGLT2 Inhibitors in ANCA-Associated Vasculitis","publication_year":2025,"publication_date":"2025-10-01","ids":{"openalex":"https://openalex.org/W4415549460","doi":"https://doi.org/10.1681/asn.2025b3sepdkh"},"language":"en","primary_location":{"id":"doi:10.1681/asn.2025b3sepdkh","doi":"https://doi.org/10.1681/asn.2025b3sepdkh","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2025b3sepdkh","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104190852","display_name":"Aditi Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aditi Singh","raw_affiliation_strings":["Johns Hopkins University, Baltimore, Maryland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, Maryland, United States","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004778580","display_name":"Oluwadamilola Adisa","orcid":"https://orcid.org/0009-0008-5476-4504","observed_orcids":["https://orcid.org/0009-0008-5476-4504"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Oluwadamilola Adisa","raw_affiliation_strings":["Johns Hopkins University, Baltimore, Maryland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, Maryland, United States","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058786394","display_name":"Duvuru Geetha","orcid":"https://orcid.org/0000-0001-8353-5542","observed_orcids":["https://orcid.org/0000-0001-8353-5542"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Duvuru Geetha","raw_affiliation_strings":["Johns Hopkins University, Baltimore, Maryland, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University, Baltimore, Maryland, United States","institution_ids":["https://openalex.org/I145311948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33607231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"10S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10697","display_name":"Vasculitis and related conditions","score":0.61080002784729,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.04740000143647194,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.03200000151991844,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/anca-associated-vasculitis","display_name":"ANCA-associated vasculitis","score":1.0},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9490000009536743},{"id":"https://openalex.org/keywords/vasculitis-relapse","display_name":"vasculitis relapse","score":0.8859999775886536},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.8230000138282776},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate-decline","display_name":"estimated glomerular filtration rate decline","score":0.8519999980926514},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.824999988079071},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8149999976158142},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.8960000276565552},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9549000263214111},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.8202000260353088},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.7404000163078308},{"id":"https://openalex.org/C2776015282","wikidata":"https://www.wikidata.org/wiki/Q644318","display_name":"Vasculitis","level":3,"score":0.6879000067710876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6448000073432922},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5670999884605408},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.459199994802475},{"id":"https://openalex.org/C54847362","wikidata":"https://www.wikidata.org/wiki/Q177635","display_name":"Nephrology","level":2,"score":0.43860000371932983},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.37279999256134033},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3357999920845032},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.3163999915122986},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2897000014781952},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2831999957561493},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.2700999975204468},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.26600000262260437},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.2628999948501587},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.2596000134944916},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25699999928474426},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.25589999556541443},{"id":"https://openalex.org/C2779668873","wikidata":"https://www.wikidata.org/wiki/Q6693756","display_name":"Lower risk","level":3,"score":0.25529998540878296}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1681/asn.2025b3sepdkh","doi":"https://doi.org/10.1681/asn.2025b3sepdkh","is_oa":false,"landing_page_url":"https://doi.org/10.1681/asn.2025b3sepdkh","pdf_url":null,"source":{"id":"https://openalex.org/S115693375","display_name":"Journal of the American Society of Nephrology","issn_l":"1046-6673","issn":["1046-6673","1533-3450"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315620","host_organization_name":"American Society of Nephrology","host_organization_lineage":["https://openalex.org/P4310315620"],"host_organization_lineage_names":["American Society of Nephrology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Society of Nephrology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3215916919","https://openalex.org/W4206773008","https://openalex.org/W7133319634","https://openalex.org/W4205112001","https://openalex.org/W4415434494","https://openalex.org/W4415270494","https://openalex.org/W7216602222","https://openalex.org/W4380626161","https://openalex.org/W7204533152","https://openalex.org/W7154138568"],"abstract_inverted_index":{"Background:":[0],"Sodium-glucose":[1],"cotransporter-2":[2],"inhibitors":[3],"(SGLT-2i)":[4],"have":[5,18],"demonstrated":[6,217],"profound":[7],"cardioprotective":[8],"and":[9,40,71,80,86,104,112,160,169,193,205],"renal":[10],"protective":[11],"benefits":[12],"in":[13,114,121,153,170,224,242],"large":[14],"clinical":[15],"trials,":[16],"which":[17],"thus":[19],"far":[20],"excluded":[21],"patients":[22,56,118,163,198,226],"with":[23,30,37,57,124,134,146,155],"vasculitis.":[24],"ANCA-associated":[25],"vasculitis":[26],"(AAV)":[27],"is":[28],"associated":[29],"higher":[31],"mortality":[32],"than":[33],"the":[34,92,156,210],"general":[35],"population,":[36],"cardiovascular":[38],"risk":[39,47],"chronic":[41],"kidney":[42],"disease":[43],"(CKD)":[44],"remaining":[45],"independent":[46],"factors.":[48],"Methods:":[49],"We":[50],"conducted":[51],"a":[52,65,76,125,149,178,200,218],"retrospective":[53],"study":[54,216,236],"of":[55,78,82,128,151,174,181,191,196,202,222],"AAV":[58,79,105,225,243],"who":[59],"started":[60],"an":[61,83],"SGLT-2":[62],"inhibitor":[63],"at":[64],"single":[66],"academic":[67],"centre":[68],"between":[69],"2021":[70],"2024.":[72],"Inclusion":[73],"criteria":[74],"included":[75,109,120],"diagnosis":[77,150],"initiation":[81,173],"SGLT-2i.":[84],"Clinical":[85],"treatment":[87],"data":[88],"were":[89,99,119,132,164],"extracted":[90],"from":[91],"electronic":[93],"medical":[94],"record.":[95],"The":[96],"primary":[97],"outcomes":[98,108],"complications":[100,185],"related":[101,186],"to":[102,187],"SGLT-2i":[103,141,175,188,223],"relapses.":[106],"Secondary":[107],"proteinuria":[110],"reduction":[111],"decline":[113],"eGFR.":[115],"Results:":[116],"Ten":[117],"this":[122],"analysis,":[123],"mean":[126,179],"age":[127],"61":[129],"years;":[130],"60%":[131],"male,":[133],"70%":[135],"having":[136],"MPO":[137],"positivity.":[138],"Indication":[139],"for":[140,237],"was":[142],"predominantly":[143],"heart":[144],"failure":[145],"or":[147],"without":[148],"CKD":[152,159],"50%,":[154],"remainder":[157],"being":[158],"diabetes.":[161],"All":[162],"on":[165],"active":[166],"immunosuppressive":[167],"therapy":[168],"remission":[171],"upon":[172],"(Fig-1)":[176],"At":[177],"follow-up":[180,212],"2.5":[182],"years,":[183],"no":[184],"required":[189],"discontinuation":[190],"medication,":[192],"1":[194],"out":[195],"10":[197],"had":[199],"relapse":[201],"AAV.":[203],"Proteinuria":[204],"eGFR":[206],"remained":[207],"stable":[208],"during":[209],"entire":[211],"period.":[213],"Conclusion:":[214],"Our":[215],"good":[219],"safety":[220],"profile":[221,241],"that":[227],"has":[228],"previously":[229],"not":[230],"been":[231],"reported.":[232],"It":[233],"warrants":[234],"additional":[235],"its":[238],"strong":[239],"nephroprotective":[240],"patients.":[244]},"counts_by_year":[],"updated_date":"2026-06-14T06:11:07.267592","created_date":"2025-10-25T00:00:00"}